Greg Pyszczymuka - Oct 3, 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Commercial Officer
Signature
/s/ Ryan J. Selhorn as attorney-in-fact for Greg Pyszczymuka
Stock symbol
AYTU
Transactions as of
Oct 3, 2025
Transactions value $
$0
Form type
4
Date filed
10/7/2025, 04:16 PM
Previous filing
May 22, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PYSZCZYMUKA GREG Chief Commercial Officer C/O AYTU BIOPHARMA, INC., 7900 EAST UNION AVENUE, SUITE 920, DENVER /s/ Ryan J. Selhorn as attorney-in-fact for Greg Pyszczymuka 2025-10-07 0001952920

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Stock Award $0 +12.5K +52.96% $0.00 36.1K Oct 3, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.

Remarks:

Exhibit 24: Power of Attorney